Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland

Abstract

Background: Following the spread of the coronavirus disease 2019 (COVID-19) pandemic a new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome temporally associated with COVID-19 (PIMS-TS), or Multisystem Inflammatory Syndrome in Children (MIS-C). In the absence of trials, evidence for treatment remains scarce. Purpose: To develop best practice recommendations for the diagnosis and treatment of children with PIMS-TS in Switzerland. It is acknowledged that the field is changing rapidly, and regular revisions in the coming months are pre-planned as evidence is increasing. Methods: Consensus guidelines for best practice were established by a multidisciplinary group of Swiss pediatric clinicians with expertise in intensive care, immunology/rheumatology, infectious diseases, hematology, and cardiology. Subsequent to literature review, four working groups established draft recommendations which were subsequently adapted in a modified Delphi process. Recommendations had to reach >80% agreement for acceptance. Results: The group achieved agreement on 26 recommendations, which specify diagnostic approaches and interventions across anti-inflammatory, anti-infectious, and support therapies, and follow-up for children with suspected PIMS-TS. A management algorithm was derived to guide treatment depending on the phenotype of presentation, categorized into PIMS-TS with (a) shock, (b) Kawasaki-disease like, and (c) undifferentiated inflammatory presentation. Conclusion: Available literature on PIMS-TS is limited to retrospective or prospective observational studies. Informed by these cohort studies and indirect evidence from other inflammatory conditions in children and adults, as well as guidelines from international health authorities, the Swiss PIMS-TS recommendations represent best practice guidelines based on currently available knowledge to standardize treatment of children with suspected PIMS-TS. Given the absence of high-grade evidence, regular updates of the recommendations will be warranted, and participation of patients in trials should be encouraged. (Copyright © 2021 Schlapbach, Andre, Grazioli, Schöbi, Ritz, Aebi, Agyeman, Albisetti, Bailey, Berger, Blanchard-Rohner, Bressieux-Degueldre, Hofer, L'Huillier, Marston, Meyer Sauteur, Pachlopnik Schmid, Perez, Rogdo, Trück, Woerner, Wütz, Zimmermann, Levin, Whittaker, Rimensberger and the PIMS-TS working group of the Interest Group for Pediatric Neonatal Intensive Care (IGPNI) of the Swiss Society of Intensive Care and the Pediatric Infectious Diseases Group Switzerland (PIGS).)eCollection. Cited Medium: Print. NLM ISO Abbr: Front Pediatr. PubMed Central ID: PMC8187755. Linked References: Br J Haematol. 2020 Sep;190(5):e274-e276. (PMID: 32652563); Pediatr Crit Care Med. 2021 Mar 1;22(3):e178-e191. (PMID: 33003176); Curr Opin Infect Dis. 2019 Oct;32(5):497-504. (PMID: 31335441); Lancet. 2020 May 16;395(10236):1569-1578. (PMID: 32423584); Lancet. 2020 May 23;395(10237):1607-1608. (PMID: 32386565); Lancet Child Adolesc Health. 2021 Feb;5(2):133-141. (PMID: 32956615); Pediatr Crit Care Med. 2020 Nov;21(11):e1031-e1037. (PMID: 32886460); Intensive Care Med. 2021 Jan;47(1):90-93. (PMID: 33057783); JAMA. 2020 Jul 21;324(3):259-269. (PMID: 32511692); J Clin Invest. 2020 Nov 2;130(11):5967-5975. (PMID: 32730233); BMJ. 2020 Jul 30;370:m2924. (PMID: 32732352); Circulation. 2020 Dec 8;142(23):2282-2284. (PMID: 33112651); N Engl J Med. 2020 Jul 23;383(4):334-346. (PMID: 32598831); Arthritis Rheumatol. 2020 Nov;72(11):1791-1805. (PMID: 32705809); Front Pediatr. 2020 Dec 16;8:626182. (PMID: 33425823); Pediatr Crit Care Med. 2021 Jan 1;22(1):56-67. (PMID: 33003177); Hum Vaccin Immunother. 2021 Jun 3;17(6):1607-1611. (PMID: 33228458); Pediatrics. 2020 Nov;146(5):. (PMID: 32855347); Rheumatology (Oxford). 2019 Apr 1;58(4):672-682. (PMID: 30535127); Arch Dis Child. 2020 Nov;105(11):1025-1027. (PMID: 32912866); Pediatr Infect Dis J. 2021 Jan;40(1):e1-e6. (PMID: 33055501); Pediatr Crit Care Med. 2010 Mar;11(2):234-8. (PMID: 19794327); Clin Infect Dis. 2021 Mar 15;72(6):1067-1073. (PMID: 32594142); Blood Adv. 2020 Dec 8;4(23):6051-6063. (PMID: 33290544); J Am Coll Cardiol. 2020 Oct 27;76(17):1947-1961. (PMID: 32890666); J Pediatr. 2021 Feb;229:33-40. (PMID: 33075369); Circulation. 2021 Jan 5;143(1):21-32. (PMID: 33166189); Pediatrics. 2020 Aug;146(2):. (PMID: 32398330); Nat Rev Immunol. 2020 Aug;20(8):453-454. (PMID: 32546853); JAMA. 2018 Jul 24;320(4):358-367. (PMID: 30043064); J Pediatr. 2020 Sep;224:24-29. (PMID: 32553861); Cell. 2020 Nov 12;183(4):968-981.e7. (PMID: 32966765); N Engl J Med. 2020 Jul 23;383(4):393-395. (PMID: 32598829); Ann Rheum Dis. 2020 Aug;79(8):999-1006. (PMID: 32527868); Intensive Care Med. 2020 Feb;46(Suppl 1):10-67. (PMID: 32030529); Curr Opin Pediatr. 2014 Jun;26(3):286-91. (PMID: 24732566); Circulation. 2017 Apr 25;135(17):e927-e999. (PMID: 28356445); N Engl J Med. 2020 Dec 17;383(25):2451-2460. (PMID: 32412710); Nat Med. 2020 Dec;26(12):1819-1824. (PMID: 33139949); Front Pediatr. 2020 Aug 28;8:490. (PMID: 32984206); Crit Care. 2020 Nov 26;24(1):666. (PMID: 33243303); Front Pediatr. 2021 Jan 05;8:594127. (PMID: 33469522); Pediatrics. 2021 Feb;147(2):. (PMID: 33234669); BMJ. 2020 Oct 19;371:m3979. (PMID: 33077431); Lancet. 2020 Jun 6;395(10239):1771-1778. (PMID: 32410760); Lancet Rheumatol. 2020 Jun;2(6):e358-e367. (PMID: 32373790); Pediatr Crit Care Med. 2005 Jan;6(1):2-8. (PMID: 15636651); J Cereb Blood Flow Metab. 2011 Feb;31(2):439-47. (PMID: 20628399); JAMA. 2021 Mar 2;325(9):855-864. (PMID: 33523115); Circulation. 2021 Jan 5;143(1):78-88. (PMID: 33166178); Nat Med. 2020 Nov;26(11):1701-1707. (PMID: 32812012); J Pediatric Infect Dis Soc. 2020 Nov 12;:. (PMID: 33180935); Cell. 2020 Nov 12;183(4):982-995.e14. (PMID: 32991843); JAMA Pediatr. 2018 Apr 1;172(4):312-314. (PMID: 29459982); Eur J Pediatr. 2021 Feb;180(2):307-322. (PMID: 32803422); JAMA. 2020 May 12;323(18):1824-1836. (PMID: 32282022); J Thromb Haemost. 2020 Nov;18(11):3099-3105. (PMID: 33174388); J Pediatric Infect Dis Soc. 2021 Feb 13;10(1):34-48. (PMID: 32918548); Pediatrics. 2020 Dec;146(6):. (PMID: 33184170); J Clin Invest. 2020 Nov 2;130(11):5942-5950. (PMID: 32701511); Lancet. 2020 ar 28;395(10229):1033-1034. (PMID: 32192578); N Engl J Med. 2020 Nov 5;383(19):1813-1826. (PMID: 32445440); EClinicalMedicine. 2020 Sep;26:100527. (PMID: 32923992). Linking ISSN: 22962360. Subset: PubMed not MEDLINE; Date of Electronic Publication: 2021 May 26. ; Original Imprints: Publication: Lausanne : Frontiers Media SA, [2013]- <br />